人
员工是我们最宝贵的财富，他们的素质、创造力和奉献精神是我们成功不可或缺的因素。
搜索人员
关于我们员工的最新消息
January 23, 2026
In the News
Kyle Faget Assesses Latest Federal Health Care Funding Actions
Foley & Lardner LLP partner Kyle Faget assessed the U.S. Department of Health and Human Service's latest federal health care funding actions in Inside Health Policy.
January 23, 2026
Deals and Wins
Foley Represents TCGX as Investor in $287M Series D1 Financing for CORXEL
Foley & Lardner LLP represented TCGX Crossover (TCGX) as an investor in the $287 million Series D1 financing for CORXEL, a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cardiometabolic conditions around the world.
January 23, 2026
Deals and Wins
Foley Represents DLB in Sale of Majority Stake to Accenture
Foley & Lardner LLP represented DLB Associates and its affiliated companies (collectively “DLB”), an industry leader and trailblazer in engineering and consulting services for data centers and related mission critical facilities, in the sale of a majority stake to Accenture (NYSE: ACN).